Coronary Stents Market Analysis

Coronary Stents Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is classified into drug-eluting stent, bioresorbable vascular scaffold (BVS), and bare metal stent. The drug eluting stent segment generated the highest revenue of USD 6.4 billion in 2024.
 

• One of the main advantages of drug-eluting stents (DES) over bare-metal stents is their ability to significantly reduce restenosis (re-narrowing of the artery) by releasing medication that prevents excessive tissue growth. This leads to better long-term outcomes, making DES the preferred option in most coronary artery disease treatments.
   
• Moreover, DES has a lower rate of restenosis, meaning fewer follow-up interventions or repeat procedures are required compared to bare-metal stents. This lower recurrence rate is attractive to patients, healthcare providers, and insurers, as it reduces healthcare costs and improves patient outcomes.
   

Based on type, the coronary stents market is classified into balloon expendable stent and self-expendable stent. The balloon expendable stent segment dominated the market in 2024 with a market share of 58.3%.
 

• Balloon-expandable stents offer high precision during placement, allowing for accurate positioning and controlled deployment. This control minimizes the risk of damaging surrounding blood vessels and makes balloon-expandable stents an effective choice in complex or narrow artery cases where precise stent placement is essential.
   
• Additionally, balloon-expandable stents are particularly beneficial for patients with complex or calcified lesions. The ability to deploy stents at high pressure using balloon expansion is advantageous in treating hardened plaque or difficult arterial blockages, which would be challenging for other stent types. This is anticipated to boost the segment's growth in the market.
   

Based on material, the coronary stents market is segmented into cobalt-chromium alloy, stainless steel, and other materials. The cobalt-chromium alloy segment dominated the market in 2024 and is anticipated to reach USD 7.6 billion by the end of forecast period.
 

• Cobalt-chromium alloy is known for its high tensile strength and durability, making it ideal for withstanding the pressure of artery walls while maintaining lumen (inner diameter) expansion. This strength allows stents made of cobalt-chromium to remain durable over time, reducing the likelihood of fractures or failures and enhancing patient outcomes.
   
• Furthermore, the high strength of cobalt-chromium allows manufacturers to create stents with thinner struts without compromising structural integrity. Thin-strut designs reduce the risk of artery injury, improve blood flow, and promote faster healing. These key advantages help reduce restenosis (re-narrowing of arteries) and thrombosis risks, leading to segmental growth.
   

Based on end use, the coronary stents market is segmented into cardiac centers, hospitals, ambulatory surgical centers, and other end users. The cardiac centers segment dominated the market in 2024 and is anticipated to reach USD 6.9 billion by the end of forecast period.
 

• Cardiac centers are staffed with specialized cardiologists, interventional radiologists, and cardiac surgeons trained to perform complex procedures, such as stent placements and angioplasties. This level of expertise is vital for high-risk patients and complex cases, making cardiac centers a trusted choice for stent procedures.
   
• Additionally, these centers are equipped with advanced diagnostic and interventional technologies, such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted systems. These technologies enhance procedural precision, allowing for accurate stent placement and reducing the risk of complications.

North America coronary stents market accounted for USD 3 billion market revenue in 2024 and is anticipated to grow at a CAGR of 6.4% between 2025 and 2034.
 

• North America, particularly the U.S., faces a significant burden of cardiovascular diseases, including coronary artery disease (CAD). Lifestyle factors such as sedentary behavior, high-fat diets, and stress contribute to a high incidence of CVDs, which, in turn, drives demand for coronary stent procedures to manage and treat these conditions.
   
• Further, the region boasts a well-developed healthcare system with state-of-the-art medical facilities, skilled healthcare providers, and easy access to advanced cardiac care. This robust infrastructure enables the widespread availability of coronary stent procedures and supports the adoption of innovative stent technologies across hospitals and cardiac centers, thereby driving regional growth.
   

Germany coronary stents market is projected to grow remarkably in the coming years.
 

• Germany is home to leading medical device companies and manufacturers of coronary stents, including BIOTRONIK, B. Braun, and other global players with strong regional operations. These companies contribute to innovation and market growth by producing high-quality, cutting-edge stent technologies.
   
• Moreover, the country’s comprehensive health insurance system covers most coronary procedures, including stent placements, reducing the financial burden on patients. Favorable reimbursement policies enable greater patient access to stent procedures, supporting consistent demand in the market.
   

China holds a dominant position in the Asia Pacific coronary stents market.
 

• China’s population is aging rapidly, with a growing proportion of elderly individuals who are more vulnerable to CVDs. The aging population is at higher risk of heart diseases, leading to increased demand for coronary stent procedures as part of the treatment for age-related cardiovascular conditions.
   
• The country is heavily investing in its healthcare infrastructure, including the development of advanced hospitals and medical centers in both urban and rural areas. As healthcare accessibility improves, the adoption of advanced technologies like coronary stents increases, especially in urban hospitals equipped with the latest medical technologies.